is proud to share the exciting news of a new drug delivery method that can reverse the senescence of stem cells. As people age, their bodies begin to change and deteriorate due to a process known as senescence. As this process affects stem cells, it presents an issue of maintaining cell culturing for therapeutic use. In a study recently published by the labs of Hyunjoon Kong (M-CELS leader/EIRH/RBTE) and Hee-Sun Han (GNDP/IGOH), a new method of delivering antioxidants to stem cells that is reliable, long-lasting, and minimizes variation has surfaced, allowing these cells to be pulled out of their senescent state and act like healthy stem cells once again.

The new method utilizes antioxidants in the form of polymer-stabilized crystals, which are generated on a small scale using microfluidics and dissolve at a slower rate than other traditional methods, providing a longer drug life period and reducing the amount of antioxidants needed to be added to the cell cultures. This also allows a larger harvest of the needed biomolecules for therapeutics, as well as creating the potential to treat patient-derived stem cell treatments.

At, we believe that this new drug delivery method is incredibly newsworthy as it offers a potential new method of treating senescent cells, reducing the rate at which cells experience senescence, and increasing the harvest of therapeutically relevant biomolecules. It’s an important breakthrough in the biomanufacturing process and could be used for various hydrophilic drugs and other drugs, disease models, and methods applications. To learn more about this exciting new discovery, read the full article here: